The Doctors’ Lounge

Send us Fan Mail

Episode Summary
Orthopedic spine surgeon and independent-practice owner Adam Bruggeman joins The Doctor’s Lounge to explain the No Surprises Act (NSA), its independent dispute resolution (IDR) process, and the controversy over how out-of-network care should be paid. Hosts Anish Koka, Anthony DiGiorgio, and Sanat Dixit examine what the dispute means for physician negotiating power, patient access, and the future of independent practice.

Timestamps
00:00 - Meet Adam Bruggeman and his health policy background
02:21 - What the No Surprises Act is designed to do
04:14 - Patient protections and baseball-style arbitration
08:33 - How often claims reach IDR, and who wins
10:54 - Why the arbitration backstop matters in contract negotiations
14:35 - The QPA and proposals to tie payments to it
19:14 - Why the hosts question QPA as a measure of physician value
23:54 - The reported $22 billion cost and uncertainty in the data
26:15 - Who pays arbitration costs, and what is known about premiums
29:08 - Why New York’s experience may not predict national claim volume
31:53 - Out-of-network strategies, physician assistants, and possible gaming
34:56 - Medicare rates, insurer market power, and physician consolidation
38:47 - Comparing NSA payments with the old out-of-network system
42:38 - Physician negotiating power and the limits of independent practice
47:10 - Cash-pay surgery, insurance, and maintaining patient access
54:39 - How arbitration decisions and offers are being scrutinized
61:08 - Why the dispute over a small share of claims matters
64:34 - Physician fees as a loss leader for hospital revenue

Co-Host Handles

@anish_koka and @DrDiGiorgio

Show Handle

@DrsLoungePod

Subscribe Links

Spotify:https://open.spotify.com/show/44vw8eirsKKnjgNIrdDvrR
Apple Podcasts:https://podcasts.apple.com/us/podcast/the-doctors-lounge/id1832097658
YouTube:https://www.youtube.com/@TheDoctorsLoungePod

🔗 Connect with the Hosts:

• Dr. Anthony DiGiorgio on X

• Dr. Anish Koka on X

• Dr. Dan Choi on X

• Dr. Sanat Dixit on X

Send us Fan Mail

Episode Summary:
In this episode, Dr. Anish Koka and Dr. Anthony DiGiorgio talk through the trade-offs of government-run programs using SNAP as a model for thinking about healthcare. They also dig into Medicaid fraud, managed care, Medicare Advantage, and the risks of bringing overt politics into patient encounters.
The discussion is grounded in real policy examples and a shared concern that well-intended programs can balloon, distort markets, and create worse outcomes if the incentives are wrong.

Timestamps
00:00 - Cold San Francisco, small talk, and setting up the policy agenda
00:01:30 - Previewing Dr. Adam Bruggeman and the next episode on IDR and the No Surprises Act
00:03:54 - Why SNAP is the right model to think about when designing healthcare subsidies
00:05:48 - No program is perfect, but SNAP may be better than the alternatives
00:06:13 - How SNAP can be gamed through cash-equivalent arbitrage and junk food purchases
00:07:11 - Why a healthcare HSA-style subsidy would still need rules on eligible spending
00:08:01 - SNAP spending has grown from about 6 billion to about 120 billion per year
00:09:07 - The risk that healthcare subsidies could also incentivize unhealthy consumption and fraud
00:11:22 - Why every government program seems to drift toward vested interests and regulatory capture
00:12:18 - The case for a market-based subsidy instead of direct government service delivery
00:13:16 - What a fully government-run food system would look like if modeled on Medicare
00:14:32 - Government-run hospitals, the VA, and the limits of parallel public systems
00:17:02 - Public schools, vouchers, and why incentive structure matters more than more money
00:18:25 - Why a subsidized private system may work better than a broad public option
00:20:46 - Tiers already exist in American healthcare, whether people admit it or not
00:22:39 - How corporate actors lobby for government intervention once subsidies exist
00:24:05 - Why a public option may preserve the same distortions rather than fix them
00:26:26 - Medicaid fraud news, investigative journalism, and the Nick Shirley reporting
00:28:59 - Medicaid fee-for-service versus managed care and the fraud-control trade-off
00:31:52 - How 1915 waiver services are especially vulnerable to abuse in fee-for-service systems
00:32:46 - The Medicare Advantage debate and disputed overpayment estimates
00:35:37 - Traditional Medicare’s own problems with fraud control and payment distortions
00:37:13 - Why price suppression harms both physicians and patients
00:40:30 - Concussion care as an example of how shortages and waitlists emerge
00:43:22 - The moral argument for prices and patient choice
00:46:26 - Critiquing the MedPage piece on doctors talking to patients about politics
00:48:46 - Why the exam room is the wrong place for political persuasion
00:50:48 - The vulnerability of the patient and why political advocacy should stay out of clinical care
00:53:19 - Why overt political endorsements can damage physician-patient trust
00:57:48 - Why academic monoculture is overstated and many dissenters are simply quiet
00:59:53 - What is coming next: IDR with Dr. Bruggeman and future healthcare and AI discussions
01:01:09 - Hoover Institute Medicare event, 340B, quality metrics, and incremental reform

Co-Host Handles
@anish_koka and @drdigiorgio

Show Handle
@drsloungepod

Subscribe Links:

Spotify: https://open.spotify.com/show/44vw8eirsKKnjgNIrdDvrR

Apple Podcasts: https://podcasts.apple.com/us/podcast/the-doctors-lounge/id1832097658

YouTube: https://www.youtube.com/@TheDoctorsLoungePod

🔗 Connect with the Hosts:

• Dr. Anthony DiGiorgio on X

• Dr. Anish Koka on X

• Dr. Dan Choi on X

• Dr. Sanat Dixit on X

Send us Fan Mail

Episode Summary

This episode examines why US healthcare keeps rewarding consolidation, even when it raises costs and makes the system harder to navigate. Andrew Tsang, writer of Health is Other People, brings a cross-industry view from consulting, policy, providers, and payers to explain how hospitals, insurers, and Medicare rules all shape behavior. We discuss why the system feels adversarial, how incentives drive consolidation, and why policies like the No Surprises Act and MLR can produce unintended consequences. The conversation also turns into a broader argument that the real problem may be cultural and existential, not just technical or legislative.

Timestamps
00:00 - Introducing Andrew Tsang and his healthcare writing background
00:53 - From consulting and Medicaid work to healthcare writing
03:10 - Why hospitals are political systems, not just businesses
05:23 - Mass General Brigham, consolidation, and incentive-driven growth
10:20 - What the No Surprises Act is trying to do for patients
12:39 - Independent dispute resolution and the provider payer dynamic
15:49 - Why arbitration may favor providers and still raise costs
18:26 - MLR, insurer incentives, and the limits of cost containment
22:19 - Why US healthcare fights over scarce resources instead of throughput
23:46 - The scale of utilization management and billing conflict
24:23 - Medicare DRGs, coding complexity, and upcoding incentives
26:24 - How hospital market power affects commercial pricing
28:28 - What actually drives merger strategy inside health systems
31:39 - Why insurers and hospitals still claim cost control while behaving differently
37:37 - The Tufts and Partners negotiation as a lesson in market power
40:33 - Essential benefits, narrow plans, and how coverage rules shape leverage
44:42 - Why the US wants both public guarantees and private market incentives
47:11 - Vertical integration in insurance and why it is rewarded
53:39 - Why policy fixes are incremental and often politically compromised
56:21 - Why Andrew left consulting and what felt futile about the work
58:18 - The case for healthcare as a cultural and moral problem
59:12 - Why selfishness, greed, and apathy may be the real barriers to reform

Co-Host Handles
@anish_koka and @drdigiorgio

Show Handle
@drsloungepod

Subscribe Links
Spotify: https://open.spotify.com/show/44vw8eirsKKnjgNIrdDvrR
Apple Podcasts: https://podcasts.apple.com/us/podcast/the-doctors-lounge/id1832097658
YouTube: https://www.youtube.com/@TheDoctorsLoungePod

Mr. Andrew Tsang LinkedIn:
linkedin.com/in/tsang1219

Mr. Andrew Tsang Substack handle is: 
https://substack.com/@andrewtsang

Mr. Andrew Tsang Substack Health is Other People link: 
https://blog.healthisotherpeople.com/?utm_source=global-search

Mr. Andrew Tsang Substack Mass General Brigham merger link:
https://substack.com/@andrewtsang/note/c-350273328?utmSource=%2Fsearch%2FMass%2520General%2520Brigham%2520merger

🔗 Connect with the Hosts:

• Dr. Anthony DiGiorgio on X

• Dr. Anish Koka on X

• Dr. Dan Choi on X

• Dr. Sanat Dixit on X

Send us Fan Mail

Episode Summary 

Dr. Mollie James joins Anish Koka, MD and Anthony DiGiorgio to talk about what pushed her out of traditional employment, how she rebuilt her practice after bankruptcy and COVID, and why she believes more physicians need independent options. The conversation focuses on the pressures of hospital employment, the power of pricing and cash pay, and practical paths for doctors who want more autonomy.

Timestamps
(00:00) Dr. Mollie James' background and the goal of the conversation
(01:41) Southern Iowa roots, DO training, surgery, ICU work, and leaving academics
(03:19) Administrative overload and trying to rebuild trauma services after a tornado
(04:43) Why job-hopping did not solve the real problem
(07:11) RVU pressure, too few ORs, and the impossible math of employed surgery
(08:29) Why administrators miss the clinical big picture
(09:59) The COVID straw that broke the camel's back
(11:49) Pushback over medication choices and committee control
(13:45) Launching James Clinic during the pandemic
(16:17) Treating 4,000 COVID patients in four months
(17:30) Telemedicine, a low-rent clinic, and building from scratch
(18:23) Cash pricing, two-week coverage, and tiered support
(19:46) Doubters, happy hypoxia, and why outpatient COVID care worked
(21:32) The treatment approach: steroids, antihistamines, and more
(23:24) ICU COVID, sedation, vent intolerance, and prolonged intubations
(25:51) Omicron, collapsing COVID volume, and pivoting the business
(27:30) Pricing mistakes, layoffs, and how a practice has to evolve
(28:10) Why the integrative cancer program was underpriced
(29:28) Current niches: hormone care, blood pressure, fatigue, mitochondrial support
(30:12) Why the market can solve care shortages better than administration
(31:46) Why cash pay and patient-funded care reduce conflict over evidence
(35:48) Independent medicine requires results, service, and rapid feedback
(36:42) Why low prices can limit your ability to help anyone
(37:24) Why physicians should consider independence and self-funded models
(40:01) Diversifying privileges and not putting all your eggs in one basket
(40:52) How a new grad can start as a 1099 contractor
(42:39) Networking, call coverage, and building cooperative physician relationships
(43:22) Why scarcity thinking hurts doctors outside the hospital
(44:56) The modifier 25 and CMS reimbursement frustrations
(46:28) Fear, pricing transparency, and why patients and doctors both lose
(47:42) Knowledge replacing fear in healthcare decisions
(49:46) Why splitting procedures across days feels absurd to patients
(50:48) The real mechanism problem behind billing rules
(53:26) Social media manipulation, CPT complexity, and administrative bloat
(55:08) Why single payer does not actually mean simple
(56:03) Maverick Medical Ventures and the playbook for leaving the system
(58:28) Headwinds, hospital consolidation, and patients seeing huge price jumps
(60:15) Monopolization, referrals blocked by system rules, and loss of access
(61:11) Why hospital privileges can still be a barrier for outpatient procedures
(62:10) Culture wars, division, and the need to align on shared physician priorities
(64:46) Closing details: James Clinic locations, Maverick Medical, and Dr. James' handle

Co-Host Handles
@anish_koka and @drdigiorgio

Show Handle
@drsloungepod

Subscribe Links
Spotify: https://open.spotify.com/show/44vw8eirsKKnjgNIrdDvrR
Apple Podcasts: https://podcasts.apple.com/us/podcast/the-doctors-lounge/id1832097658
YouTube: https://www.youtube.com/@TheDoctorsLoungePod

Dr. Mollie James X Handle
@molsjames

Dr. Mollie James Website
https://maverickmedicalventures.com/

🔗 Connect with the Hosts:

• Dr. Anthony DiGiorgio on X

• Dr. Anish Koka on X

• Dr. Dan Choi on X

• Dr. Sanat Dixit on X

Send us Fan Mail

Summary

In this episode, Anthony DiGiorgio and Anish Koka engage with Tom Wolf, a recovery advocate, who shares his personal journey through addiction, homelessness, and eventual recovery. The conversation delves into the complexities of homelessness, the impact of substance use, and the evolving definitions and policies surrounding addiction treatment. Tom discusses the harm reduction approach, its origins, and its implications, while emphasizing the need for accountability and the role of physicians in addressing the opioid crisis. The episode highlights the importance of lived experiences in shaping drug policy and the ongoing challenges faced by individuals in recovery. In this conversation, Anthony DiGiorgio and Tom Wolf delve into the complexities of addiction treatment, mental health, and the political landscape surrounding these issues. They discuss the challenges of psychiatric holds, the balance between autonomy and compulsion in treatment, and the failures of current drug policies in major cities. The dialogue emphasizes the need for a recovery-oriented system of care and critiques the harm reduction approach, drawing comparisons to international policies, particularly in Portugal. The conversation highlights the intersection of mental health and addiction, the political ramifications of policy failures, and the urgent need for effective solutions to the ongoing drug crisis.

Chapters
00:00 Introduction to Recovery Advocacy
00:55 Tom Wolf's Journey Through Addiction
06:33 Finding Recovery and Advocacy
10:08 The Complexity of Homelessness and Addiction
11:22 The Evolving Definition of Homelessness
12:26 The Impact of Substance Use on Housing
15:06 Harm Reduction: A Double-Edged Sword
20:30 The Role of Physicians in Substance Abuse
25:02 The Historical Context of Opioid Prescription
30:02 The Future of Drug Policy and Recovery
34:39 Navigating Psychiatric Holds and Treatment Options
38:30 The Dilemma of Autonomy vs. Compulsion in Treatment
40:40 Evaluating Policy Failures in Major Cities
44:51 Building a Recovery-Oriented System of Care
47:39 Comparing Drug Policies: Lessons from Portugal
49:40 The Intersection of Mental Health and Addiction
51:51 The Political Landscape of Addiction Recovery
56:55 The Challenges of Acknowledging Policy Failures

Co-Host Handles

@anish_koka and @drdigiorgio

Show Handle

@drsloungepod

Guest Handle/Links

@Twolfrecovery

https://www.tomwolfrecovery.com/

Subscribe Links

Spotify: http://open.spotify.com/show/44vw8eirsKKnjgNIrdDvrR

Apple Podcasts: https://podcasts.apple.com/us/podcast/the-doctors-lounge/id1832097658

YouTube: https://www.youtube.com/@TheDoctorsLoungePod

🔗 Connect with the Hosts:

• Dr. Anthony DiGiorgio on X

• Dr. Anish Koka on X

• Dr. Dan Choi on X

• Dr. Sanat Dixit on X

Send us Fan Mail

Episode Summary 

Rachel Rosenthal, an editorial board member at Bloomberg who writes on healthcare and education, joins Anthony DiGiorgio and Anish Koka for a wide-ranging conversation about healthcare reporting, COVID-era lessons, and why Medicare’s fiscal path matters beyond policy circles. The discussion gets into the incentives behind drug pricing, the limits of simplistic villains in healthcare, and why trade-offs, not slogans, are what actually shape reform.
In this episode, Rachel shares how an accidental path from Asia and immigration policy led her into healthcare editorial writing, why the beat is both endlessly frustrating and endlessly rich, and how COVID in Singapore changed the way she thinks about public health authority, institutional trust, and policy mistakes. The conversation also turns to her Bloomberg piece on Medicare, where the hosts unpack how spending, deficits, borrowing, and bond markets connect.

Timestamps
00:00 - Intro and guest introduction
00:51 - Rachel’s accidental path from Asia to healthcare writing
03:25 - Why healthcare is a “gift that keeps on giving”
04:57 - From Medicare to digital twins, the range of the beat
06:48 - Why healthcare has no single villain
08:17 - The real work behind strong healthcare editorials
10:04 - How COVID in Singapore changed her perspective
11:40 - Lockdowns, surveillance, and zero-COVID enforcement
14:30 - What the pandemic revealed about institutions and trust
18:18 - Why Singapore’s approach was understandable, then failed to adapt
20:18 - Writing columns that forced policy change
23:46 - How school closures exposed institutional dysfunction
24:38 - Leadership failures and the need for honesty
26:47 - Why source diversity matters in journalism
29:35 - The pressure to publish fast and simplify complex stories
31:04 - Are readers, editors, and advertisers all part of the problem?
35:18 - Why Medicare is the next major fiscal crisis
36:38 - The “one dollar in, three dollars out” problem
39:34 - Why uncapped spending removes urgency
40:04 - Site-neutral payments and other low-hanging fruit
41:31 - Why wealthy seniors still receive subsidies
43:33 - How entitlement reform gets politically messy
45:41 - Why Medicare matters to bond traders
47:01 - Interest rates, mortgages, and everyday life
48:30 - Demographics, aging, and the scale of the problem
49:22 - Why Medicare for All doesn’t solve the deficit
52:06 - Medicare’s complexity and the limits of copying it
55:52 - A simple framework: government choices versus private choice
57:57 - Who decides preventive care coverage and why that is political
59:45 - Health policy as a value judgment, not pure math
62:12 - Rachel’s ideal direction: less employer-sponsored distortion, more individual choice
64:54 - Defining the real problem before designing reform
66:27 - Trade-offs, privilege, and the appeal of security
68:01 - Why innovation in delivery and payment still matters
69:14 - Why good-faith debate disappears when the frame becomes good versus evil
71:07 - Why both left and right need to give ground
72:35 - Universal catastrophic coverage as a possible compromise
73:35 - Security, coverage gaps, and the need for on-ramps between programs
74:32 - Wrap-up and final thoughts

Co-Host Handles
@anish_koka and @DrDiGiorgio

Show handle

@DRsLoungePod

Subscribe Links
Spotify: https://open.spotify.com/show/44vw8eirsKKnjgNIrdDvrR
Apple Podcasts: https://podcasts.apple.com/us/podcast/the-doctors-lounge/id1832097658
YouTube: https://www.youtube.com/@TheDoctorsLoungePod

🔗 Connect with the Hosts:

• Dr. Anthony DiGiorgio on X

• Dr. Anish Koka on X

• Dr. Dan Choi on X

• Dr. Sanat Dixit on X

Send us Fan Mail

In this special add-on episode, Anish Koka and Anthony DiGiorgio welcome Dr. James O'Leary — a Mayo-trained OB-GYN with forty years of experience, former department chairman, ACO board member, and host of the Real Doc Speaks podcast — for a wide-ranging conversation on the erosion of physician-led care. The trio dissects a tragic Nashville case in which four outpatient knee-replacement patients were injected with potassium phosphate instead of bupivacaine after a multi-step, multi-person medication-verification process failed at every checkpoint, using it as a jumping-off point to discuss "kludgeocracy," alert fatigue, surgical-timeout mission creep, and how doctors who raise safety concerns get labeled disruptive. From there the conversation moves through OB-GYN malpractice and nuclear jury verdicts, Florida's no-fault birth-injury compensation fund as a possible national model, the maze of state-by-state Medicaid reimbursement and its perverse incentives, and nonprofit hospitals' use of stadium sponsorships as a possible anti-kickback violation, before closing with a rapid-fire "hot seat" round covering ACOs, private equity, scope of practice, physician unionization, and single-payer healthcare.

Chapters

00:00 Cold open — why isn't Medicaid money reaching physicians?

00:34 Welcoming Dr. James O'Leary (Real Doc Speaks)

02:34 Why physicians need a voice on social media

03:14 The Nashville potassium phosphate medication error

09:52 Would a physician-owned hospital have prevented this?

10:17 "Kludgeocracy" and getting labeled disruptive

14:30 The surgical timeout's mission creep

19:35 EMR alert fatigue and lost safety signals

22:50 Replacing pharmacy techs with better safeguards

24:34 Anish's shift from hospital to outpatient practice

30:19 Malpractice, nuclear verdicts, and OB-GYN

33:50 Florida's no-fault birth-injury compensation model

39:16 Medicaid reimbursement and state-by-state variation

50:33 Nonprofit hospitals, sports sponsorships, and the anti-kickback statute

55:46 Five hot-seat questions for Dr. O'Leary

1:01:51 Direct referrals vs. large health systems

1:03:23 Closing thoughts and where to find Dr. O'Leary

Co-Host Handles

@anish_koka and @drdigiorgio

Guest Handle

Dr. James O'Leary — @realdocspeaks

Show Handle

@drsloungepod

Subscribe Links: 

Spotify: http://open.spotify.com/show/44vw8eirsKKnjgNIrdDvrR

Apple Podcasts: https://podcasts.apple.com/us/podcast/the-doctors-lounge/id1832097658

YouTube: https://www.youtube.com/@TheDoctorsLoungePod

🔗 Connect with the Hosts:

• Dr. Anthony DiGiorgio on X

• Dr. Anish Koka on X

• Dr. Dan Choi on X

• Dr. Sanat Dixit on X

Send us Fan Mail

Episode Summary
Anthony DiGiorgio and Anish Koka speak with Dr. Ashish Jha, co-founder and CEO of BioRadar, senior fellow at Harvard Belfer Center, and former White House COVID-19 response coordinator, about the future of American healthcare policy. The conversation moves from hospital pricing and insurance design to Medicaid, HSA-based models, and the political realities that shape what reform is actually possible. They also pivot into a second major topic: biothreat detection. Jha explains why he thinks biosurveillance, not just response, will be essential in an era of AI-assisted biological engineering.

Timestamps
00:00 - Intro, guest credentials, and the Boston Globe cost cure series
00:33 - Why Jha wrote a 10-part reform series instead of one op-ed
01:54 - Evidence-based ideas that should annoy someone on every side
03:42 - Why state-level health policy matters, not just Washington
04:20 - American healthcare’s core pricing problem
05:58 - Competition, monopolies, and when price regulation enters the picture
06:57 - Scope of practice, insurance design, and administrative burden
08:40 - Indiana’s Medicaid-based hospital pricing experiment
09:47 - Why provider price caps are controversial
11:42 - Site-neutral payments and the hospital lobbying problem
13:30 - Why temporary regulation can bridge a monopoly-heavy market
16:22 - Why payer competition matters before price caps can reach consumers
17:44 - Can temporary government policies ever really be reversed?
20:11 - Tackling the demand-side subsidies that fuel consolidation
22:39 - FTC enforcement and the slow pace of market change
23:53 - Why policy experts should give leaders workable alternatives
26:27 - Hospitals are not villains, but incentives matter
27:32 - Site-neutral payment and physician-owned hospitals as starting points
28:57 - Cash payments, deductibles, and value-based insurance design
29:49 - The outline of a possible deal among hospitals, insurers, and policymakers
33:34 - Medicaid work requirements and what the evidence says
35:36 - Why eligibility should be easier for people who qualify
38:02 - Medicaid as a value statement about universal coverage
40:19 - Program integrity, fraud, and long-term sustainability
43:43 - Why Jha changed his mind on pay-for-performance and EHRs
45:14 - His critique of quality metrics and the value of empirical humility
46:14 - Why HSAs are attractive but imperfect
47:23 - Living under an HSA and why behavior changes
49:47 - Why Medicare for All is politically and operationally hard
50:41 - Uwe Reinhardt, Denmark, and why systems depend on politics and people
53:18 - Why sick people often make irrational cost decisions
57:02 - Smarter copays, true emergencies, and the limits of consumerism
58:24 - Why disagreement should stay respectful and not personal
60:20 - Pivot to bioterrorism and biological weapons
61:07 - Why BioRadar was created and what problem it is solving
63:18 - AI, state actors, and the shrinking barrier to bioweapons
64:18 - Why the risk of an engineered pathogen in the next five years worries Jha
65:31 - Jha’s view that COVID was more likely a lab leak than a natural origin
66:30 - Guardrails around gain-of-function research and Fauci criticism
68:46 - The difference between a dangerous outbreak and a stealth pandemic
71:38 - How biosurveillance can avoid overreaction while still catching real threats
73:13 - Why better surveillance could have changed the COVID response
75:16 - Wrap-up, bipartisanship, and the value of trade-offs

Co-Host Handles
@anish_koka and @DrDiGiorgio
Show Handle
@DRsLoungePod

Subscribe Links
Spotify: https://open.spotify.com/show/44vw8eirsKKnjgNIrdDvrR
Apple Podcasts: https://podcasts.apple.com/us/podcast/the-doctors-lounge/id1832097658
YouTube: https://www.youtube.com/@TheDoctorsLoungePod

🔗 Connect with the Hosts:

• Dr. Anthony DiGiorgio on X

• Dr. Anish Koka on X

• Dr. Dan Choi on X

• Dr. Sanat Dixit on X

Send us Fan Mail

Episode Summary 

In this episode of the Doctor's Lounge, Anthony DiGiorgio speaks with Hon. Tom Oliverson, MD, Texas State Representative for House District 130 and chair of the House Republican Caucus. Dr. Oliverson shares how he moved from medicine into public service, why practicing physicians should remain involved in policymaking, and what Texas is doing to address healthcare affordability. They also dig into 340B, prior authorization reform, and the origins of the No Surprises Act.

Chapter Markers
00:00 - Introduction to Dr. Tom Oliverson and his Texas healthcare policy role
01:24 - From Cut and Shoot to Baylor and a medical career
05:01 - Why running for office felt like a calling
08:02 - Why Texas lawmakers are expected to keep real jobs
13:30 - The healthcare affordability committee and the expert testimony it drew
16:28 - Consolidation as a major driver of healthcare cost growth
18:49 - Why direct contracting may replace traditional networks
22:49 - What the future could look like in a Singapore-style transparent market
23:53 - ERISA limits, state authority, and the frustration of federal preemption
25:17 - Medicaid payment, fraud, and what states can still influence
28:06 - Using Medicaid buying power to push back on abusive pharmacy practices
29:15 - 340B as a “Robin Hood” program with perverse incentives
36:03 - Why Texas is pushing transparency on 340B revenue and pricing
37:38 - The gold carding law and prior authorization reform
43:43 - A Capitol cardiac arrest and a real-life case with Dr. Bonnen
46:35 - What Texas can and cannot regulate in state insurance markets
48:47 - Texas roots of the No Surprises Act
51:43 - How Texas arbitration was designed to define fair market value
54:25 - Why the federal NSA lost key guardrails
61:41 - Texas opt-in for ERISA plans and why that matters
66:49 - Cash deductible credit when patients choose cheaper care
68:45 - Compounding, GLP-1 dosing, and preserving access through customization
70:09 - Peptides, prevention, food access, and the case for lifestyle-based care
72:34 - Closing thoughts on free markets, 340B, and healthy food

Co-Host Handles

@anish_koka and @DrDiGiorgio

Show Handle

@DRsLoungePod

Subscribe Links
Spotify: https://open.spotify.com/show/44vw8eirsKKnjgNIrdDvrR

Apple Podcasts: https://podcasts.apple.com/us/podcast/the-doctors-lounge/id1832097658 

YouTube: https://www.youtube.com/@TheDoctorsLoungePod

Official Texas House Select Committee on Health Care Affordability page:

https://house.texas.gov/committees/committee/059

Dr. Tom Oliverson on X:

https://x.com/TomOliverson

🔗 Connect with the Hosts:

• Dr. Anthony DiGiorgio on X

• Dr. Anish Koka on X

• Dr. Dan Choi on X

• Dr. Sanat Dixit on X

Send us Fan Mail

The prior uploaded file had 26 seconds that was corrupted.  Restored on this version!

Episode Summary:
Dr. Vinay Prasad joins the Doctors Lounge in a recorded in person conversation that moves from his time at the FDA to bigger questions about evidence, incentives, and trust in medicine. The discussion focuses on how regulatory agencies actually function, why public health debates have become so politicized, and whether the current healthcare funding model rewards good care or just expensive care.

Timestamps:
00:16 - Why the FDA conversation matters now
02:49 - Why Vinay accepted the DC job
04:02 - What can actually change inside the FDA
05:39 - The Exondys approval and commissioner authority
07:22 - Do appointees really steer regulatory decisions?
09:48 - Should the FDA regulate safety or efficacy?
10:31 - Safety, efficacy, and the car analogy
13:04 - Could COVID vaccines have been released earlier?
14:04 - Challenge trials versus large community trials
16:32 - Rolling out vaccines by age and risk
18:05 - Why post COVID myocarditis comparisons are flawed
22:36 - The danger of elite stamped misinformation
24:06 - When medicine became political
26:24 - Why institutions may be too captured to trust
27:24 - The measles death story and missing context
30:17 - Buchanan, Tullock, and the logic of bureaucracy
33:17 - How healthcare swallows trillions with mixed value
35:02 - Why low back surgery is hard to centralize
37:27 - ICD placement and gray zone medicine
39:07 - Who should pay for marginal cancer drugs?
41:10 - Demand subsidies and distorted prices
43:34 - Innovation before large welfare programs
46:53 - Does more money always mean more innovation?
48:48 - Why journalism misses what matters at FDA
51:21 - The No Surprises Act and who really pays
55:42 - Vinay’s broader career path and what comes next
57:34 - Why active clinical practice still matters

Co-Host Handles
@anish_koka and @drdigiorgio
Show Handle
@drsloungepod

Subscribe Links
Spotify: https://open.spotify.com/show/44vw8eirsKKnjgNIrdDvrR
Apple Podcasts: https://podcasts.apple.com/us/podcast/the-doctors-lounge/id1832097658
YouTube: https://www.youtube.com/@TheDoctorsLoungePod

Dr. DiGiorgio's project "Off Label Ideas"
https://www.offlabelideas.com/

Dr. DiGiorgio's on Substack
https://substack.com/@drdigiorgio

🔗 Connect with the Hosts:

• Dr. Anthony DiGiorgio on X

• Dr. Anish Koka on X

• Dr. Dan Choi on X

• Dr. Sanat Dixit on X